Denmark· DK-28106591421
QUVIVIQ
A daridorexant product containing daridorexant hydrochlorid, registered in Denmark by Idorsia Pharmaceuticals Deutschland GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Daridorexant is registered in 15 of 19 countries.
Countries holding a registration under ATC N05CJ03 (daridorexant), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Daridorexant · ATC N05CJ03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of daridorexant costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Daridorexant · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- FR France$3.24
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Daridorexant hydrochlorid
- Manufacturer
- Idorsia Pharmaceuticals Deutschland GmbH
- Country
- Denmark (DK)
- ATC code
- N05CJ03
- ATC class
- Daridorexant
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106591421
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05CJ03
Daridorexant, as other registers publish it.
- IcelandQuviviqIdorsia Pharmaceuticals Deutschland GmbH
- IcelandQuviviqIdorsia Pharmaceuticals Deutschland GmbH
- NorwayQuviviqIdorsia
- CzechiaQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- FinlandQUVIVIQParanova Oy
- FinlandQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH
- PolandQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH
- CzechiaQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa058de1-65d4-4495-a0a3-8edd022bf15f GET /v1/drugs/fa058de1-65d4-4495-a0a3-8edd022bf15f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "50 mg",
"auth_role": "MOD",
"dk_drugid": "28106591421",
"substance": "Daridorexant hydrochlorid",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44680"
}See everything about daridorexant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.